跳至主要内容
临床试验/IRCT138711211666N1
IRCT138711211666N1已完成2 期

Phase 2 Study of Assessing the Effect of Ultra-Low-Dose Naloxone on Accentuating the Effect of Fentanyl on Enhancing the Local Anesthetic Characteristic of Lidocaine

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria: Distal Radius Fracture;

排除标准

  • Diabetes mellitus, Addiction, Recent analgesic or narcotic medication.

研究者

相似试验

进行中(未招募)
1 期
A study of ixazomib plus lenalidomide plus dexamethasoen (IRd) for newly diagnosed transplant-eligible myeloma patientsMultiple myeloma newly diagnosed transplant-eligible patientsMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864
EUCTR2015-004863-35-LTHelsinki University Hospital Comprehensive Cancer Center Hematology120
进行中(未招募)
1 期
A study of ixazomib plus lenalidomide plus dexamethasone (IRd) for newly diagnosed transplant-eligible myeloma patientsMultiple myeloma newly diagnosed transplant-eligible patientsMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864
EUCTR2015-004863-35-FIHospital District of Helsinki and Uusimaa/Helsinki University Hospital HUS120
进行中(未招募)
1 期
A study of ixazomib plus lenalidomide plus dexamethasoen (IRd) for newly diagnosed transplant-eligible myeloma patients
EUCTR2015-004863-35-SEHelsinki University Hospital Comprehensive Cancer Center Hematology120
进行中(未招募)
1 期
A study of ixazomib plus lenalidomide plus dexamethasoen (IRd) for newly diagnosed transplant-eligible myeloma patientsMultiple myeloma newly diagnosed transplant-eligible patientsMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864
EUCTR2015-004863-35-NOHelsinki University Hospital Comprehensive Cancer Center Hematology120
尚未招募
4 期
TO OBSERVE THE EFFECT OF LOW LEVEL LASER THERAPY ON APICAL ROOT RESORPTION OCCURING DURING ORTHODONTIC TREATMENT AT THE STAGE OF MAXILLARY CANINE RETRACTION USING THE ARCH WIRES NANO COATED WITH PARYLENE.RANDOMIZED CONTROLLED TRIAL AND CBCT STUDY.
CTRI/2023/10/058291Dr.Prajakta Joshi